clinicial trials

GSK’s niraparib meets PFS goal in phase 3 PRIMA trial
Pharmaceutical Business Review
Tue, 10/1/19 - 09:56 am
GSK
clinicial trials
niraparib
Zejula
advanced ovarian cancer